| February 15, 2013 | News for the transfusion medicine and cellular therapy community |
 |  |
- PRP linked to benefits for patients with knee osteoarthritis
 Platelet-rich plasma therapy improved pain and function scores for patients with knee osteoarthritis one year after the treatment, according to findings published in the Clinical Journal of Sport Medicine. The condition did not progress in 73% of cases. The study used magnetic resonance imaging and other evaluation tools to assess PRP results. Healio/Orthopedics Today
(2/13)     
|
|
Variety is the spice of life.
That's why Quotient sources cells from US, Europe and Asia for its new to the market antibody screens and ID panels, helping you rule out and rule in antibodies. GPOs must like variety too, because Quotient has new contracts with Premier, Amerinet and GSA, saving you money. Find out how the one company focused on manual testing can serve you in 2013 and beyond. |
| Science & Health |  |  |
|
- Study to explore stem cell therapy for diabetic retinopathy
A European Union-supported study will explore the use of adult bone marrow stem cells in treating diabetic retinopathy. Researchers are set to grow the cells in the laboratory and plan to transplant them in patients in an attempt to repair damaged blood vessels and retinas and to restore vision. Human trials are slated to be conducted in Denmark after preclinical tests at several sites in Europe. Diabetes.co.uk (U.K.)
(2/14)
- Researchers report progress with experimental dengue vaccine
Researchers at the International Centre for Genetic Engineering and Biotechnology in New Delhi said they are making strides with a vaccine for the dengue virus, which is being developed with technology used to make hepatitis B vaccine. Preclinical tests showed the vaccine addressed all of the four dengue virus strains, researchers said. Human trials are estimated to be at least five years away. Deutsche Welle (Germany)
(2/14)
- Experts tie chemotherapy to slight increase in AML risk
Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers had an increased risk of developing acute myeloid leukemia, a study found. However, chemotherapy was associated with lower AML risk in ovarian cancer and myeloma, researchers said. HealthDay News
(2/14)
| Emerging Trends | | |
|
- Study assesses radiation exposure before kidney transplant
A new study that evaluates exposure to medical imaging ionizing radiation among patients during procedures ahead of kidney transplantation finds that nuclear stress testing accounts for the majority of overall radiation exposure. The research was published in the Clinical Journal of the American Society of Nephrology. "The effects of radiation upon malignancy risk and strategies to reduce this radiation exposure warrant further investigation," according to researchers. Renal and Urology News
(2/12)
| Industry News & Practice | | |
|
| Government & Regulatory | | |
|
- Federal officials make the case for EHR usability
EHRs need to be usable, benefit doctors and work within the health care facility's systems so as not to waste the investment made on these technologies, officials with the ONC and National Institute of Standards and Technology said at a recent conference. Meaningful use certification and keeping the provider end-user in mind when designing EHRs are some ways to achieve EHR usability, they said. Healthcare IT News
(2/12)
| Association News | | |
|
-
AABB releases rates for 2013 Annual Meeting and CTTXPO
AABB has released the registration and housing rates for the 2013 Annual Meeting and CTTXPO, which will be held in Denver. Registration and housing opens June 5 for AABB members and June 26 for general attendees. More information is available online.
| SmartQuote | | |
|
 | If you want to live a happy life, tie it to a goal. Not to people or things."
--Albert Einstein,
German-born theoretical physicist
|
| |
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AABB SmartBrief Issues:
- Thursday, February 14, 2013
- Wednesday, February 13, 2013
- Tuesday, February 12, 2013
- Monday, February 11, 2013
- Friday, February 08, 2013
| | | Lead Editor: Tom Parks
Managing Editor: Jennifer Garfinkel
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.® Legal Information |
|
